Literature DB >> 23543376

Profile of microRNAs in the plasma of Parkinson's disease patients and healthy controls.

Lucía F Cardo, Eliecer Coto, Lorena de Mena, Renée Ribacoba, Germán Moris, Manuel Menéndez, Victoria Alvarez.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23543376     DOI： 10.1007/s00415-013-6900-8

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  15 in total

1.  Identification of blood microRNAs associated to Parkinsonĭs disease.

Authors:  Regina Margis; Rogério Margis; Carlos R M Rieder
Journal:  J Biotechnol       Date:  2011-02-03       Impact factor: 3.307

2.  Pathogenic LRRK2 negatively regulates microRNA-mediated translational repression.

Authors:  Stephan Gehrke; Yuzuru Imai; Nicholas Sokol; Bingwei Lu
Journal:  Nature       Date:  2010-07-29       Impact factor: 49.962

3.  MicroRNA profiling of Parkinson's disease brains identifies early downregulation of miR-34b/c which modulate mitochondrial function.

Authors:  Elena Miñones-Moyano; Sílvia Porta; Georgia Escaramís; Raquel Rabionet; Susana Iraola; Birgit Kagerbauer; Yolanda Espinosa-Parrilla; Isidre Ferrer; Xavier Estivill; Eulàlia Martí
Journal:  Hum Mol Genet       Date:  2011-05-10       Impact factor: 6.150

4.  Accuracy of clinical diagnosis of idiopathic Parkinson's disease: a clinico-pathological study of 100 cases.

Authors:  A J Hughes; S E Daniel; L Kilford; A J Lees
Journal:  J Neurol Neurosurg Psychiatry       Date:  1992-03       Impact factor: 10.154

5.  A MicroRNA feedback circuit in midbrain dopamine neurons.

Authors:  Jongpil Kim; Keiichi Inoue; Jennifer Ishii; William B Vanti; Sergey V Voronov; Elizabeth Murchison; Gregory Hannon; Asa Abeliovich
Journal:  Science       Date:  2007-08-31       Impact factor: 47.728

Review 6.  Stages in the development of Parkinson's disease-related pathology.

Authors:  Heiko Braak; Estifanos Ghebremedhin; Udo Rüb; Hansjürgen Bratzke; Kelly Del Tredici
Journal:  Cell Tissue Res       Date:  2004-08-24       Impact factor: 5.249

7.  Repression of alpha-synuclein expression and toxicity by microRNA-7.

Authors:  Eunsung Junn; Kang-Woo Lee; Byeong Seon Jeong; Teresa W Chan; Joo-Young Im; M Maral Mouradian
Journal:  Proc Natl Acad Sci U S A       Date:  2009-07-23       Impact factor: 11.205

8.  Age-related differences in the expression of circulating microRNAs: miR-21 as a new circulating marker of inflammaging.

Authors:  Fabiola Olivieri; Liana Spazzafumo; Gabriele Santini; Raffaella Lazzarini; Maria Cristina Albertini; Maria Rita Rippo; Roberta Galeazzi; Angela Marie Abbatecola; Fiorella Marcheselli; Daniela Monti; Rita Ostan; Elisa Cevenini; Roberto Antonicelli; Claudio Franceschi; Antonio Domenico Procopio
Journal:  Mech Ageing Dev       Date:  2012-10-02       Impact factor: 5.432

Review 9.  Genetic etiology of Parkinson disease associated with mutations in the SNCA, PARK2, PINK1, PARK7, and LRRK2 genes: a mutation update.

Authors:  Karen Nuytemans; Jessie Theuns; Marc Cruts; Christine Van Broeckhoven
Journal:  Hum Mutat       Date:  2010-07       Impact factor: 4.878

10.  Circulatory miR34a as an RNAbased, noninvasive biomarker for brain aging.

Authors:  Xiaoli Li; Amit Khanna; Na Li; Eugenia Wang
Journal:  Aging (Albany NY)       Date:  2011-10       Impact factor: 5.682
View more
  63 in total

Review 1.  Role of viruses, prions and miRNA in neurodegenerative disorders and dementia.

Authors:  Sayed Sartaj Sohrab; Mohd Suhail; Ashraf Ali; Mohammad Amjad Kamal; Azamal Husen; Fahim Ahmad; Esam Ibraheem Azhar; Nigel H Greig
Journal:  Virusdisease       Date:  2018-09-29

2.  Serum miR-30c-5p is a potential biomarker for multiple system atrophy.

Authors:  Annamaria Vallelunga; Tommaso Iannitti; Giovanna Dati; Sabrina Capece; Marco Maugeri; Ersilia Tocci; Marina Picillo; Giampiero Volpe; Autilia Cozzolino; Massimo Squillante; Giulio Cicarelli; Paolo Barone; Maria Teresa Pellecchia
Journal:  Mol Biol Rep       Date:  2019-02-27       Impact factor: 2.316

Review 3.  MicroRNAs in Parkinson's disease.

Authors:  Abhishek Singh; Dwaipayan Sen
Journal:  Exp Brain Res       Date:  2017-05-19       Impact factor: 1.972

4.  Plasma levels of miR-137 and miR-124 are associated with Parkinson's disease but not with Parkinson's disease with depression.

Authors:  Na Li; Xudong Pan; Jingli Zhang; Aijun Ma; Shaonan Yang; Juanjuan Ma; Anmu Xie
Journal:  Neurol Sci       Date:  2017-02-08       Impact factor: 3.307

Review 5.  Deregulation of α-synuclein in Parkinson's disease: Insight from epigenetic structure and transcriptional regulation of SNCA.

Authors:  Subhrangshu Guhathakurta; Eugene Bok; Baggio A Evangelista; Yoon-Seong Kim
Journal:  Prog Neurobiol       Date:  2017-04-23       Impact factor: 11.685

6.  Hydrogen peroxide responsive miR153 targets Nrf2/ARE cytoprotection in paraquat induced dopaminergic neurotoxicity.

Authors:  Madhusudhanan Narasimhan; Amanjot Kaur Riar; Mary Latha Rathinam; Dhanashree Vedpathak; George Henderson; Lenin Mahimainathan
Journal:  Toxicol Lett       Date:  2014-05-24       Impact factor: 4.372

Review 7.  Are microRNAs true sensors of ageing and cellular senescence?

Authors:  Justin Williams; Flint Smith; Subodh Kumar; Murali Vijayan; P Hemachandra Reddy
Journal:  Ageing Res Rev       Date:  2016-11-27       Impact factor: 10.895

Review 8.  The roles of non-coding RNAs in Parkinson's disease.

Authors:  Maryam Majidinia; Aynaz Mihanfar; Reza Rahbarghazi; Alireza Nourazarian; BakiyeGoker Bagca; Çığır Biray Avci
Journal:  Mol Biol Rep       Date:  2016-08-05       Impact factor: 2.316

Review 9.  Are circulating microRNAs peripheral biomarkers for Alzheimer's disease?

Authors:  Subodh Kumar; P Hemachandra Reddy
Journal:  Biochim Biophys Acta       Date:  2016-06-02

Review 10.  Peripheral Biomarkers for Early Detection of Alzheimer's and Parkinson's Diseases.

Authors:  Thein Than Htike; Sachin Mishra; Sundramurthy Kumar; Parasuraman Padmanabhan; Balázs Gulyás
Journal:  Mol Neurobiol       Date:  2018-07-14       Impact factor: 5.590
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.